An exploratory study of metabolomics in endogenous and cannabis-use-associated psychotic-like experiences in adolescence

被引:0
|
作者
Karoliina Kurkinen [1 ]
Olli Kärkkäinen [2 ]
Soili M. Lehto [3 ]
Ilona Luoma [4 ]
Siiri-Liisi Kraav [5 ]
Petri Kivimäki [1 ]
Sebastian Therman [6 ]
Tommi Tolmunen [7 ]
机构
[1] Institute of Clinical Medicine,Department of Psychiatry, Faculty of Medicine, University of Helsinki
[2] University of Eastern Finland,undefined
[3] School of Pharmacy,undefined
[4] University of Eastern Finland,undefined
[5] Institute of Clinical Medicine,undefined
[6] University of Oslo,undefined
[7] R&D Department,undefined
[8] Division of Mental Health Services,undefined
[9] Akershus University Hospital,undefined
[10] Yliopistonkatu 3,undefined
[11] Department of Child Psychiatry,undefined
[12] Kuopio University Hospital,undefined
[13] Department of Social Sciences,undefined
[14] University of Eastern Finland,undefined
[15] Mental Health Team,undefined
[16] Finnish Institute for Health and Welfare,undefined
[17] Kuopio University Hospital,undefined
[18] Department of Adolescent Psychiatry,undefined
关键词
D O I
10.1038/s41398-024-03163-9
中图分类号
学科分类号
摘要
In adolescence, psychotic-like experiences (PLE) may indicate potential prodromal symptoms preceding the onset of psychosis. Metabolomic studies have shown promise in providing valuable insights into predicting psychosis with enhanced precision compared to conventional clinical features. This study investigated metabolomic alterations associated with PLE in 76 depressed adolescents aged 14–20 years. Serum concentrations of 92 metabolites were analyzed with liquid chromatography–mass spectrometry. PLE were assessed using the Youth Experiences and Health (YEAH) questionnaire. The associations between PLE symptom dimensions (delusions, paranoia, hallucinations, negative symptoms, thought disorder, and dissociation) and metabolite concentrations were analyzed in linear regression models adjusted for different covariates. The symptom dimensions consistently correlated with the metabolome in different models, except those adjusted for cannabis use. Specifically, the hallucination dimension was associated with 13 metabolites (acetoacetic acid, allantoin, asparagine, decanoylcarnitine, D-glucuronic acid, guanidinoacetic acid, hexanoylcarnitine, homogentisic acid, leucine, NAD+, octanoylcarnitine, trimethylamine-N-oxide, and valine) in the various linear models. However, when adjusting for cannabis use, eight metabolites were associated with hallucinations (adenine, AMP, cAMP, chenodeoxycholic acid, cholic acid, L-kynurenine, neopterin, and D-ribose-5-phosphate). The results suggest diverse mechanisms underlying PLE in adolescence; hallucinatory experiences may be linked to inflammatory functions, while cannabis use may engage an alternative metabolic pathway related to increased energy demand and ketogenesis in inducing PLE. The limited sample of individuals with depression restricts the generalizability of these findings. Future research should explore whether various experiences and related metabolomic changes jointly predict the onset of psychoses and related disorders.
引用
收藏
相关论文
共 50 条
  • [1] Are Cannabis Induced Psychotic-Like Experiences (PLEs) Associated with the Frequency of Cannabis Use?
    Hides, Leanne
    Quinn, Catherine
    EARLY INTERVENTION IN PSYCHIATRY, 2016, 10 : 105 - 105
  • [2] CIGARETTE SMOKING IS EQUALLY STRONGLY ASSOCIATED WITH PSYCHOTIC-LIKE EXPERIENCES AS CANNABIS USE
    Boks, Marco P. M.
    van Gastel, W. A.
    Schubart, C. D.
    Vreeker, A.
    Tempelaar, W.
    MacCabe, J. H.
    Kahn, R.
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S9 - S9
  • [3] Cannabis use and psychotic-like experiences trajectories during early adolescence: the coevolution and potential mediators
    Bourque, Josiane
    Afzali, Mohammad H.
    O'Leary-Barrett, Maeve
    Conrod, Patricia
    JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2017, 58 (12) : 1360 - 1369
  • [4] Are deficits in cognition associated with psychotic-like experiences after cannabis?
    Barkus, Emma
    Morrison, Paul
    Di Forti, Marta
    Murray, Robin M.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2016, 31 (06) : 402 - 411
  • [5] NEUROCOGNITIVE DEFICITS ARE ASSOCIATED WITH PSYCHOTIC-LIKE EXPERIENCES AFTER CANNABIS
    Barkus, Emma
    Smith, L.
    Diforti, M.
    Murray, R.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 259 - 260
  • [6] NEUROCOGNITIVE DEFICITS ARE ASSOCIATED WITH PSYCHOTIC-LIKE EXPERIENCES AFTER CANNABIS
    Barkus, Emma
    Smith, L.
    Diforti, M.
    Murray, R.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 267 - 267
  • [7] Distal and proximal risk factors of problematic cannabis use associated with psychotic-like experiences
    Johnstone, Samantha
    Wong, Cassandra
    Girard, Todd A.
    Kim, Hyoun S.
    ADDICTIVE BEHAVIORS, 2024, 152
  • [8] Psychotic-like experiences from adolescence to adulthood: A longitudinal study
    Isaksson, Johan
    Angenfelt, Max
    Frick, Matilda A.
    Olofsdotter, Susanne
    Vadlin, Sofia
    SCHIZOPHRENIA RESEARCH, 2022, 248 : 1 - 7
  • [9] Psychotic-like experiences and cannabis use in adolescents from the general population
    Fonseca-Pedrero, Eduardo
    Lucas-Molina, Beatriz
    Perez-Albeniz, Alicia
    Inchausti, Felix
    Ortuno-Sierra, Javier
    ADICCIONES, 2020, 32 (01) : 41 - 51
  • [10] Patterns of cannabis use, psychotic-like experiences and personality styles in young cannabis users
    Spriggens, Lauren
    Hides, Leanne
    SCHIZOPHRENIA RESEARCH, 2015, 165 (01) : 3 - 8